-
Cancer Drug Leaves 12 Diabetic Patients Blind, Pakistan Health Officials Launch Investigation -
Alzheimer’s Drug Breakthrough Big Boost for Roche, Eli Lilly -
Roche’s Single-Dose Influenza Drug Granted FDA Approval for Children Aged 5 and Over -
Roche Launches Dual Antigen and Antibody Diagnostic Test for Hepatitis C -
Roche Says FDA Grants Priority Review to Actemra for COVID-19 -
Swissmedic Approves Roche’s Ronapreve to Treat COVID-19 Patients -
Roche Says At-Home COVID-19 Rapid Test Gets Ok From FDA -
Roche Develops New Research Test Kits for Omicron Variant -
Roche Shareholders Approve Deal to Buy Novartis’s $20.7 Billion Stake -
COVID-19 Antiviral Pill From Roche, Atea Fails to Help Patients With Mild or Moderate Symptoms -
Roche to Cut 300–400 Product Development Jobs: Swiss Newspaper -
Roche Looking for New Place to Test COVID-19 Pill After Cases Plummet in UK -
Roche Wins US Nod for COVID-19 Antibody Test, Aims to Boost Output -
Private Sector to Ramp up Production of COVID-19 Test Kits, Throughput in Labs Insufficient to Screen All: CEO -
2 Companies on Track to Manufacture Millions of Coronavirus Tests -
US Government Issues Emergency Approval for New Coronavirus Test -
Popular Asthma Drug Fraudulently Marketed by Pharma Companies: Whistleblowers